Pseudomonas Superbug Develops Fast Resistance to ‘Last Resort’ Antibiotic
Mutations in a gene known as pmrB allow the bacteria Pseudomonas to evolve resistance to Colistin, a "last resort" antibiotic.
Mutations in a gene known as pmrB allow the bacteria Pseudomonas to evolve resistance to Colistin, a "last resort" antibiotic.
NIH will conduct a clinical trial to test the antibiotic dalbavancin for safety and efficacy in treating complicated Staphylococcus aureus (S. aureus) bacteremia.
Engineering researchers developed a device that uses magnetic nano-beads to isolate minute particles that cause diseases. The new research is published in in the journal ACS Applied Materials and Interfaces.
A new study has found that telavancin, a current treatment for hospital-acquired pneumonia, could be a potential treatment against MRSA in patients with cystic fibrosis.
Read MoreRespiratory therapists play a crucial role in minimizing intubated patients’ risk of exposure to MDROs and VAP by following proper protocols solutions that help prevent infections.
Read MoreIn a video for MD Magazine, researchers talk in depth about current and developing agents for...
Read MoreNew research from Lund University in Sweden shows for the first time how bacteria in the airways can help each other replenish vital iron, Science Daily reports.
Read MoreBoosting a key immune process called autophagy with interferon gamma (IFN-γ) could help clear a lethal bacterial infection in cystic fibrosis, a new study suggests.
Read MoreIn addition to the constant threat of ventilator-associated pneumonia, ventilated patients also face dangers from other less common hospital-acquired infections, including waterborne pathogens that can occur during humidification.
Read MoreAn antimicrobial peptide produced by human immune cells can promote mutations in P. aeruginosa bacterium, a common cause of death in cystic fibrosis patients.
Read MoreWhen the bacterium Yersinia pestis enters the lungs, it causes pneumonic plague, a disease that is 100 percent fatal if untreated. The way in which Y. pestis evades the immune system and kills people in a matter of days has largely confounded scientists, until now.
Read MoreResearchers uncovered the 3-D structure of the a protein that confers antibiotic resistance methicillin-resistant Staphylococcus aureus (MRSA). The find may allow researchers to develop an effective antibiotic against the bacterial superbug.
Read MoreResearchers from Doctors Without Borders say a lack of candidate compounds is “cause for alarm,” given the global emergence of strains of tuberculosis that are resistant to current drugs.
Read MoreEvery year 160 million prescriptions for antibiotics are written in the United States, nearly 30 prescriptions per 100 persons. Probably half are inappropriate.
Read More